Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $74,205 | $86,180 | $1,615,797 | $1,095,415 |
| % Growth | -13.9% | -94.7% | 47.5% | – |
| Cost of Goods Sold | $478,645 | $572,827 | $620,967 | $513,871 |
| Gross Profit | -$404,440 | -$486,647 | $994,830 | $581,544 |
| % Margin | -545% | -564.7% | 61.6% | 53.1% |
| R&D Expenses | $506,499 | $579,720 | $474,648 | $448,006 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$323,774 | -$382,062 | -$312,886 | -$287,213 |
| Operating Expenses | $182,725 | $197,658 | $161,762 | $160,793 |
| Operating Income | -$587,165 | -$684,305 | $833,068 | $420,751 |
| % Margin | -791.3% | -794% | 51.6% | 38.4% |
| Other Income/Exp. Net | $64,060 | $56,111 | -$78,788 | $129,051 |
| Pre-Tax Income | -$523,105 | -$628,194 | $754,280 | $549,802 |
| Tax Expense | -$1,145 | -$13,077 | $238,443 | $21,218 |
| Net Income | -$521,960 | -$615,061 | $515,837 | $528,584 |
| % Margin | -703.4% | -713.7% | 31.9% | 48.3% |
| EPS | -3.83 | -4.59 | 3.89 | 4.07 |
| % Growth | 16.6% | -218% | -4.4% | – |
| EPS Diluted | -3.83 | -4.59 | 3.83 | 3.96 |
| Weighted Avg Shares Out | 136,247 | 134,131 | 132,607 | 129,885 |
| Weighted Avg Shares Out Dil | 136,247 | 134,131 | 134,811 | 133,437 |
| Supplemental Information | – | – | – | – |
| Interest Income | $71,809 | $86,990 | $28,092 | $439 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $14,559 | $19,451 | $6,783 | $5,811 |
| EBITDA | -$508,912 | -$641,637 | $839,851 | $426,562 |
| % Margin | -685.8% | -744.5% | 52% | 38.9% |